Saturday, July 6, 2019

Statin Use Associated With Higher Incidence of Diabetes

›
In continuation of my update on statins There may be a dose-dependent relationship between statin therapy and new-onset diabetes across...
Wednesday, July 3, 2019

FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients

›
The U.S. Food and Drug Administration today approved Mavyret (telaprevir and pibrentasvir) tablets to treat all six genotypes of hepatit...
Tuesday, July 2, 2019

FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes

›
In continuation of my update on  dapagliflozin , and metformin hydrochloride   Dapagliflozin               Saxagliptin    ...
Sunday, June 30, 2019

FDA Approves Duobrii (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis In Adults

›
In continuation of my update on    tazarotene   Ulobetasol                                                                        ...
Saturday, June 29, 2019

Agios Announces FDA Approval of Tibsovo as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy

›
Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases,  announced th...
Friday, June 28, 2019

FDA Approves Ruzurgi (amifampridine) for Children with Lambert-Eaton Myasthenic Syndrome

›
In continuation of my update on  amifampridine The U.S. Food and Drug Administration approved Ruzurgi (amifampridine) tablets for ...
Thursday, June 27, 2019

FDA Approves Bavencio (avelumab) Plus Inlyta (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma

›
In continuation of my update on axitinib Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business a...
Tuesday, June 25, 2019

Common Diabetes Drug Invokana (canagliflozin) May Also Shield Kidneys, Heart

›
In continuation of my update on canagliflozin A common diabetes drug may also greatly reduce the odds for death from kidney failure and...
Saturday, June 22, 2019

Balversa (erdafitinib) Approved for Advanced Bladder Cancer

›
Balversa (erdafitinib) has been approved by the U.S. Food and Drug Administration to treat adults with advanced or spreading bladder cance...
Friday, June 21, 2019

Mayzent Approved for Relapsing MS

›
Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis (MS)....
Thursday, June 20, 2019

FDA Approves First Generic Naloxone Nasal Spray Against Opioid Overdose

›
In continuation of my update on  naloxone       The first generic   naloxone   nasal spray to treat opioid overdose has re...